Dr. Parker conducts qualitative and mixed-methods research on women and minority health issues. She currently serves as the Principle Investigator for "Be PrEPared!" to assess the effectiveness of digital storytelling and multi-strategies interventions aimed at raising knowledge, awareness, and intent to use pre-exposure prophylactics (PrEP) among women of color, and the "Lend Us Your Voice" Project, a qualitative study which examines the lived experience of HIV positive African American women in the South. She is also the PI of a HIV risk assessment study that examines multiple variables associated with contracting HIV, social vulnerabilities, and HIV risk perceptions among African American women. Her evaluation research projects have included examining predictor variables to assess the likelihood of using PrEP among diverse population, and evaluating the "Hope in Our Soul" and" Dose of Hope" interventions to increase minority participation in clinical trials. Dr. Parker's has also served as the qualitative researcher/evaluator for the HIV Prevention Trials Network (HPTN) ISIS 064 grant in the Atlanta-Metropolitan area, a two year prospective study to estimate the overall HIV type 1 incidence rates among women at risk for HIV acquisition. She was also the qualitative evaluator for a Phase I clinical trial to assess safety, tolerability, and product acceptability of a vaginal mircobicide gel (UC781) being studied to prevent HIV transmission.